S. Akira, Pathogen recognition by innate immunity and its signaling, Proceedings of the Japan Academy, Series B, vol.85, issue.4, pp.143-56, 2009.
DOI : 10.2183/pjab.85.143

A. Moustafa, A. Al-awadhi, R. Missaoui, and N. , Human papillomaviruses-related cancers, Human Vaccines & Immunotherapeutics, vol.130, issue.7, p.10, 2014.
DOI : 10.1186/1750-9378-7-38

J. Andersen, D. Al-khairy, and R. Inqalls, Innate Immunity at the Mucosal Surface: Role of Toll-Like Receptor 3 and Toll-Like Receptor 9 in Cervical Epithelial Cell Responses to Microbial Pathogens1, Increased Toll-like Receptor 9 Expression in Cervical Neoplasia in Tunisian Women, pp.824-855, 2006.
DOI : 10.1095/biolreprod.105.048629

D. Bhattacharya and N. Yusuf, Expression of Toll-Like Receptors on Breast Tumors: Taking a Toll on Tumor Microenvironment, International Journal of Breast Cancer, vol.71, issue.5, 2012.
DOI : 10.1124/pr.109.001073

E. Boccardo, A. Lepique, and L. Villa, The role of inflammation in HPV carcinogenesis, Carcinogenesis, vol.31, issue.11, pp.1905-1917, 2010.
DOI : 10.1093/carcin/bgq176

C. Bodelon, M. Madeleine, L. Johnson, Q. Du, D. Galloway et al., Genetic variation in the TLR and NF-?B pathways and cervical and vulvar cancer risk: a population-based case-control study, 2014.

L. Chang, C. Leng, and Y. Yeh, Toll-like receptor 9 agonist enhances anti-tumor immunity and inhibits tumor-associated immunosuppressive cells numbers in a mouse cervical cancer model following recombinant lipoprotein therapy, Molecular Cancer, vol.13, issue.1, p.60, 2014.
DOI : 10.1158/1535-7163.MCT-10-0827

X. Chen, S. Wang, and L. Liu, A Genetic Variant in the Promoter Region of Toll-Like Receptor 9 and Cervical Cancer Susceptibility, DNA and Cell Biology, vol.31, issue.5, pp.766-71, 2012.
DOI : 10.1089/dna.2011.1427

Y. Cheng, X. Qi, and J. Huang, Toll-like receptor 4 signaling promotes the immunosuppressive cytokine production of human cervical cancer, Eur J Gynaecol Oncol, vol.33, pp.291-295, 2012.

Q. Dai, X. Li, L. Chai, H. Long, and Z. Yang, Polymorphisms of Toll-like receptor 9 are associated with nasopharyngeal carcinoma susceptibility, Tumor Biology, vol.54, issue.4, pp.3247-53, 2014.
DOI : 10.1111/j.1348-0421.2010.00248.x

I. Daud, M. Scott, and Y. Ma, Association between toll-like receptor expression and human papillomavirus type 16 persistence, International Journal of Cancer, vol.11, issue.Suppl 1, pp.879-86, 2011.
DOI : 10.1158/1078-0432.CCR-05-0616

URL : http://onlinelibrary.wiley.com/doi/10.1002/ijc.25400/pdf

C. Decarlo, R. B. Jackson, and R. , Toll-Like Receptor Transcriptome in the HPV-Positive Cervical Cancer Microenvironment, Clinical and Developmental Immunology, vol.6, issue.7, p.785825, 2012.
DOI : 10.1155/2010/781235

H. Doan, K. Bowen, L. Jackson, and B. Evers, Toll-like receptor 4 activation increases Akt phosphorylation in colon cancer cells, Anticancer Res, vol.29, pp.2473-78, 2009.

A. El-andaloussi, A. Sonabend, Y. Han, and M. Lesniak, Stimulation of TLR9 with CpG ODN enhances apoptosis of glioma and prolongs the survival of mice with experimental brain tumors, Glia, vol.15, issue.6, pp.526-561, 2006.
DOI : 10.4049/jimmunol.165.12.7125

M. Geller, S. Cooley, and P. Argenta, Toll-like receptor-7 agonist administered subcutaneously in a prolonged dosing schedule in heavily pretreated recurrent breast, ovarian, and cervix cancers, Cancer Immunology, Immunotherapy, vol.3, issue.Suppl 66, pp.1877-84, 2010.
DOI : 10.3233/BD-2002-15109

S. Gonzalez-reyes, J. Fernandez, and L. Gonzalez, Study of TLR3, TLR4, and TLR9 in prostate carcinomas and their association with biochemical recurrence, Cancer Immunology, Immunotherapy, vol.164, issue.18, pp.217-243, 2011.
DOI : 10.1016/S0022-5347(05)67457-5

S. Hanley, E. Yoshioka, and Y. Ito, An Exploratory Study of Japanese Fathers' Knowledge of and Attitudes towards HPV and HPV Vaccination: Does Marital Status Matter?, Asian Pacific Journal of Cancer Prevention, vol.15, issue.4, pp.1837-1880, 2014.
DOI : 10.7314/APJCP.2014.15.4.1837

U. Hasan, E. Bates, and F. Takeshita, TLR9 Expression and Function Is Abolished by the Cervical Cancer-Associated Human Papillomavirus Type 16, The Journal of Immunology, vol.178, issue.5, pp.3186-97, 2007.
DOI : 10.4049/jimmunol.178.5.3186

U. Hasan, C. Zannetti, and P. Parroche, The Human papillomavirus type 16 E7 oncoprotein induces a transcriptional repressor complex on the Toll-like receptor 9 promoter, The Journal of Experimental Medicine, vol.12, issue.7, pp.1369-87, 2013.
DOI : 10.1016/j.virol.2004.08.009

A. Hasimu, L. Ge, Q. Li, R. Zhang, and X. Guo, Expressions of Toll-like receptors 3, 4, 7, and 9 in cervical lesions and their correlation with HPV16 infection in Uighur women, Chinese Journal of Cancer, vol.30, issue.5, pp.344-50, 2011.
DOI : 10.5732/cjc.010.10456

I. Hirsch, C. Caux, U. Hasan, N. Bendriss-vermare, and D. Olive, Impaired Toll-like receptor 7 and 9 signaling: from chronic viral infections to cancer, Trends in Immunology, vol.31, issue.10, pp.391-398, 2010.
DOI : 10.1016/j.it.2010.07.004

R. Karim, C. Meyers, and C. Backendorf, Human Papillomavirus Deregulates the Response of a Cellular Network Comprising of Chemotactic and Proinflammatory Genes, PLoS ONE, vol.14, issue.3, p.17848, 2011.
DOI : 10.1371/journal.pone.0017848.s009

W. Kim, J. Lee, and J. Choi, Increased expression of Toll-like receptor 5 during progression of cervical neoplasia, International Journal of Gynecological Cancer, vol.18, issue.2, 2008.
DOI : 10.1111/j.1525-1438.2007.01008.x

A. Krug, F. A. Barchet, and W. , TLR9-Dependent Recognition of MCMV by IPC and DC Generates Coordinated Cytokine Responses that Activate Antiviral NK Cell Function, Immunity, vol.21, issue.1, pp.107-126, 2004.
DOI : 10.1016/j.immuni.2004.06.007

Z. Lai, . Ni-zhang, X. Pan, and L. Song, ) gene polymorphisms associated with increased susceptibility of human papillomavirus-16 infection in patients with cervical cancer, Journal of International Medical Research, vol.8, issue.4, pp.1027-1063, 2013.
DOI : 10.1186/1750-9378-8-4

J. Lee, J. Choi, and E. Seos, Increased toll-like receptor 9 expression in cervical neoplasia, Molecular Carcinogenesis, vol.105, issue.11, pp.941-988, 2007.
DOI : 10.4049/jimmunol.175.12.8242

J. Li, L. Kang, and Y. Qiao, Review of the cervical cancer disease burden in mainland China, Asian Pac J Cancer Prev, vol.12, pp.1149-53, 2011.

L. Liu, Y. Li, and Y. Niu, An apple oligogalactan prevents against inflammation and carcinogenesis by targeting LPS/TLR4/NF-??B pathway in a mouse model of colitis-associated colon cancer, Carcinogenesis, vol.31, issue.10, pp.1822-1854, 2010.
DOI : 10.1093/carcin/bgq070

J. Lund, A. Sato, S. Akira, R. Medzhitov, and I. , Toll-like Receptor 9???mediated Recognition of Herpes Simplex Virus-2 by Plasmacytoid Dendritic Cells, The Journal of Experimental Medicine, vol.83, issue.3, pp.513-533, 2003.
DOI : 10.1099/0022-1317-83-7-1535

K. Mason and N. Hunter, CpG plus radiotherapy: a review of preclinical works leading to clinical trial, Frontiers in Oncology, vol.2, pp.1-6, 2012.
DOI : 10.3389/fonc.2012.00101

C. Mai, Y. Kang, and M. Pichika, Should a Toll-like receptor 4 (TLR-4) agonist antagonist be designed to treat cancer ? TLR-4 : its expression and effects in the most common cancers, Onco targets Ther, vol.6, pp.1573-87, 2013.

M. Moreno-eutimio, G. Altamirano, and V. Vargas-hernández, Expression of toll-like receptor 9 in cervical intraepithelial neoplasia from Mexican women, J Cytol Histol, vol.4, issue.4, 2013.

M. Mvundura and V. Tsu, Estimating the costs of cervical screening in high-burden Sub-Saharian African countries, 2014.

A. Ochi, C. Graffeo, and C. Zambrinis, Toll-like receptor 7 regulates pancreatic carcinogenesis in mice and humans, Journal of Clinical Investigation, vol.122, issue.11, pp.4118-4147, 2012.
DOI : 10.1172/JCI63606DS1

URL : http://www.jci.org/articles/view/63606/files/pdf

P. Ohlschlager, E. Spies, G. Alvarez, M. Quetting, and M. Groettrup, The combination of TLR-9 adjuvantation and electroporation-mediated delivery enhances in vivo antitumor responses after vaccination with HPV-16 E7 encoding DNA, International Journal of Cancer, vol.23, issue.14, pp.473-81, 2011.
DOI : 10.4049/jimmunol.171.11.5908

L. Oliveira, K. Louvanto, and A. Ramanakumar, Cohort Study. Polymorphism in the promoter region of the Toll-like receptor 9 gene and cervical human papillomavirus infection, 2013.

N. Othman and N. Othman, Detection of Human Papillomavirus DNA in Routine Cervical Scraping Samples: Use for a National Cervical Cancer Screening Program in a Developing Nation, Asian Pacific Journal of Cancer Prevention, vol.15, issue.5, pp.2245-2254, 2014.
DOI : 10.7314/APJCP.2014.15.5.2245

S. Pandey, B. Mittal, and M. Srivastava, Evaluation of Toll-like receptors 3 (c.1377C/T) and 9 (G2848A) gene polymorphisms in cervical cancer susceptibility, Molecular Biology Reports, vol.36, issue.7, pp.4715-4736, 2011.
DOI : 10.1007/s11033-008-9338-9

A. Roszak, M. Lianeri, A. Sowi?ska, and P. Jagodzi?ski, Involvement of toll-like receptor 9 polymorphism in cervical cancer development, Molecular Biology Reports, vol.30, issue.8, pp.8425-8455, 2012.
DOI : 10.1002/jor.21494

A. Sajadian, A. Tabarraei, and H. Soleimanjahi, Comparing the effect of Toll-like receptor agonist adjuvants on the efficiency of a DNA vaccine, Archives of Virology, vol.57, issue.8, 2014.
DOI : 10.1007/s00262-008-0459-8

B. Schmausser, M. Andrulis, S. Endrich, H. Muller-hermelink, and M. Eck, Toll-like receptors TLR4, TLR5 and TLR9 on gastric carcinoma cells: An implication for interaction with Helicobacter pylori, International Journal of Medical Microbiology, vol.295, issue.3, pp.179-85, 2005.
DOI : 10.1016/j.ijmm.2005.02.009

C. Schmidt, Immune System's Toll-like Receptors Have Good Opportunity for Cancer Treatment, JNCI: Journal of the National Cancer Institute, vol.98, issue.9, pp.574-579, 2006.
DOI : 10.1093/jnci/djj198

URL : https://academic.oup.com/jnci/article-pdf/98/9/574/7688733/djj198.pdf

I. Sheyhidin, G. Nabi, and A. Hasim, Overexpression of TLR3, TLR4, TLR7 and TLR9 in esophageal squamous cell carcinoma, World Journal of Gastroenterology, vol.17, issue.32, pp.3745-51, 2011.
DOI : 10.3748/wjg.v17.i32.3745

D. Spaner and A. Masellis, Toll-like receptor agonists in the treatment of chronic lymphocytic leukemia, Leukemia, vol.175, issue.1, pp.53-60, 2007.
DOI : 10.1038/nri1391

H. Wagner, Innate immunity's path to the Nobel Prize 2011 and beyond, European Journal of Immunology, vol.10, issue.Pt 1, pp.1089-92, 2012.
DOI : 10.1038/nri2850

URL : http://onlinelibrary.wiley.com/doi/10.1002/eji.201242404/pdf

C. Wang, S. Cao, and Y. Yang, TLR9 expression in glioma tissues correlated to glioma progression and the prognosis of GBM patients, BMC Cancer, vol.167, issue.8, p.415, 2010.
DOI : 10.1093/neuonc/nop047

J. Wang, Y. Yang, and W. Dong, Application of Human Papillomavirus in Screening for Cervical Cancer and Precancerous Lesions, Asian Pacific Journal of Cancer Prevention, vol.14, issue.5, pp.2979-82, 2013.
DOI : 10.7314/APJCP.2013.14.5.2979

Y. Wang, L. Li, and S. Wei, Human Papillomavirus (HPV) Infection in Women Participating in Cervical Cancer Screening from 2006 to 2010 in Shenzhen City, South China, Asian Pacific Journal of Cancer Prevention, vol.14, issue.12, pp.7483-87, 2006.
DOI : 10.7314/APJCP.2013.14.12.7483

J. Werner, C. Decarlo, N. Escott, I. Zehbe, and M. Ulanova, Expression of integrins and Toll-like receptors in cervical cancer: Effect of infectious agents, Innate Immunity, vol.108, issue.1, pp.55-69, 2012.
DOI : 10.1016/0092-8674(93)90231-E

Y. Weng, Y. Wang, and Y. Shi, TLR9 expression and its role in chemosensitivity to DDP in human cervical cancer cells in vitro, Journal of Huazhong University of Science and Technology [Medical Sciences], vol.110, issue.6, pp.550-554, 2011.
DOI : 10.1182/blood-2006-09-044776

H. Yang, H. Zhou, and P. Feng, Reduced expression of Toll-like receptor 4 inhibits human breast cancer cells proliferation and inflammatory cytokines secretion, Journal of Experimental & Clinical Cancer Research, vol.29, issue.1, p.92, 2010.
DOI : 10.1093/jnci/dji403

L. Yu, L. Wang, and M. Li, Expression of toll-like receptor 4 is down-regulated during progression of cervical neoplasia, Cancer Immunology, Immunotherapy, vol.57, issue.7, pp.1021-1029, 2010.
DOI : 10.4049/jimmunol.175.9.6042

L. Yu, L. Wang, and C. S. , Dual character of Toll-like receptor signalling: pro-tumorigenic effects and anti-tumor functions, Bio Bio Acta, vol.1835, pp.144-54, 2013.

Q. Zhou, K. Zhu, and H. Cheng, Toll-Like Receptors in Human Papillomavirus Infection, Archivum Immunologiae et Therapiae Experimentalis, vol.9, issue.7, pp.203-218, 2013.
DOI : 10.1016/j.intimp.2008.12.017

G. Zolini, G. Lima, and L. N. , Defense against HSV-1 in a murine model is mediated by iNOS and orchestrated by the activation of TLR2 and TLR9 in trigeminal ganglia, Journal of Neuroinflammation, vol.11, issue.1, pp.11-20, 2014.
DOI : 10.1186/1742-2094-11-20

Z. Hausen and H. , Papillomaviruses in the causation of human cancers ??? a brief historical account, Virology, vol.384, issue.2, pp.260-265, 2009.
DOI : 10.1016/j.virol.2008.11.046